Short answer
Relay Therapeutics, Inc. (RLAY) filed an 8-K current report with the SEC on March 11, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Bylaws amended March 6, 2026 to require all Securities Act/Exchange Act claims be filed in federal district court only.
Relay Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Bylaws amended March 6, 2026 to require all Securities Act/Exchange Act claims be filed in federal district court only
- Exclusive federal forum clause limits shareholders' ability to bring securities litigation in state courts
- Company retains right to consent to alternative forum on a case-by-case basis, preserving flexibility
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Relay Therapeutics, Inc. 8-K filings
Get the next RLAY 8-K as it lands
Follow RLAY for push alerts, or ask the research agent what this filing means.